APPROACHES IN METASTATIC PD-L1 NEGATIVE NSCLC

Alessandra Curioni

Switzerland
4 May 2026
}
14 min
Sponsored Interview by MSD & AstraZeneca

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates